Alternative Data for Absci
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 3 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 16,000 | Sign up | Sign up | Sign up |
| Employee Rating | 60 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | 244 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 18 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,003 | Sign up | Sign up | Sign up |
| X Followers | 3,329 | Sign up | Sign up | Sign up |
| X Mentions | 12 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 644 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 28 | Sign up | Sign up | Sign up |
| Linkedin Employees | 177 | Sign up | Sign up | Sign up |
About Absci
Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster.
| Price | $3.02 |
| Target Price | Sign up |
| Volume | 2,730,000 |
| Market Cap | $454M |
| Year Range | $2.34 - $5 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Absci Corporation (ABSI) Presents at 44th Annual J.P. Morgan Healthcare Conference - SlideshowJanuary 16 - SeekingAlpha |
|
Absci Corporation (ABSI) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 14 - SeekingAlpha |
 |
Absci just downgraded at Morgan Stanley, here's whyJanuary 8 - Thefly.com |
 |
Absci Unveils Preclinical Data for AI-Designed ABS-201, Targeting a Novel Hormonal Pathway for Hair Loss TreatmentDecember 31 - Yahoo |
 |
Absci Corporation (ABSI) Announces First Participants Dosed In Phase 1/2a HEADLINE TrialDecember 30 - Yahoo Entertainment |
 |
Absci Corporation (ABSI) Draws Full Buy Consensus With 150% Upside PotentialDecember 27 - Yahoo Entertainment |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 380,000 | 0 | 380,000 | -29M | -26M | -0.200 |
| Q2 '25 | 590,000 | 20M | -20M | -31M | -28M | -0.240 |
| Q1 '25 | 1.2M | 16M | -15M | -26M | -25M | -0.210 |
| Q4 '24 | 670,000 | 17M | -16M | -29M | -25M | -0.250 |
| Q3 '24 | 1.7M | 3.4M | -1.7M | -27M | -24M | -0.241 |
Insider Transactions View All
| VAN HOUTEN FRANS filed to buy 63,320 shares at $3.7. December 9 '25 |
| Bedrick Todd filed to buy 180,428 shares at $2.7. September 24 '25 |
| Pangalos Menelas N filed to buy 113,960 shares at $2.7. September 24 '25 |
| Busch Andreas filed to buy 327,264 shares at $3. July 29 '25 |
| Jonasson Zachariah filed to sell 384,751 shares at $5. June 14 '24 |
Similar companies
Read more about Absci (ABSI) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Absci
The Market Cap of Absci is $454M.
Currently, the price of one share of Absci stock is $3.02.
The ABSI stock price chart above provides a comprehensive visual representation of Absci's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Absci shares. Our platform offers an up-to-date ABSI stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Absci (ABSI) does not offer dividends to its shareholders. Investors interested in Absci should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Absci are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
